Cargando…

1432. County-Wide Pediatric IPD Experience Following Prevnar 13 Implementation

BACKGROUND: Although invasive pneumococcal disease (IPD) has declined following pneumococcal conjugate vaccines, both respiratory (R-IPD; e.g., pneumonias +/− empyema) and nonrespiratory IPD (NR-IPD) remain concerning. We evaluate 13-valent pneumococcal conjugate vaccine (PCV13) impact on county-wid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nieves, Delma, Osborne, Stephanie, Cheung, Michele, Arrieta, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254071/ http://dx.doi.org/10.1093/ofid/ofy210.1263

Ejemplares similares

1675. Community Acquired Serious Bacterial Infections in Pediatric Patients Before and After COVID: Could Masks Save Lives?
por: Arrieta, Antonio C, et al.
Publicado: (2023)

1432. Population-based Surveillance of Carbapenem-Resistant Enterobacteriaceae (CRE) in Alameda County, 2017-2020
por: Horwich-Scholefield, Sam, et al.
Publicado: (2020)

Mathematical Modelling Long-Term Effects of Replacing Prevnar7 with Prevnar13 on Invasive Pneumococcal Diseases in England and Wales
por: Choi, Yoon Hong, et al.
Publicado: (2012)

From “Glivec(®)” to “Prevnar 13(®)”: How strong is the Indian drug patenting system?
por: Raj, Gerard Marshall
Publicado: (2018)

926. Outbreak of Invasive Nontuberculous Mycobacterium (NTM) Infections Associated With a Pediatric Dental Practice
por: Singh, Jasjit, et al.
Publicado: (2018)

Rapid kinetics of serum IgA after vaccination with Prevnar(®)13 followed by Pneumovax(®)23
por: Crowther, Rebecca R., et al.
Publicado: (2017)

Value Added by the Prevnar 13 Childhood Immunization Program in Alberta, Canada (2010–2015)
por: Waye, Arianna, et al.
Publicado: (2015)

Sequential administration of Prevnar 13™ and PNEUMOVAX™ 23 in healthy participants 50 years of age and older
por: Buchwald, Ulrike K., et al.
Publicado: (2021)

1432. Patient-Reported Urinary Tract Infection Symptoms Among Veterans with Neurogenic Bladder
por: Fitzpatrick, Margaret A, et al.
Publicado: (2021)

1432. Estimating the Incubation Period of Salmonella Urinary Tract Infection (UTI) Using Foodborne Outbreak Data
por: Jacobs Slifka, Kara M, et al.
Publicado: (2019)

A recombinant conjugated pneumococcal vaccine that protects against murine infections with a similar efficacy to Prevnar-13
por: Reglinski, Mark, et al.
Publicado: (2018)

Direct and Indirect Impact of 13-valent Pneumococcal Conjugate Vaccine (PCV13) on Invasive Pneumococcal Disease (IPD) Among Children and Adults in the U.S.
por: Pilishvili, Tamara, et al.
Publicado: (2017)

1184. A Phase 3, Multicenter, Randomized, Double-blind Study to Evaluate the Interchangeability of V114 and Prevnar 13™ with Respect to Safety, Tolerability, and Immunogenicity in Healthy Infants (PNEU-DIRECTION)
por: Bili, Adroniki, et al.
Publicado: (2021)

Excess Risk of Invasive Pneumococcal Disease (IPD) Persists in Adults with Comorbid Conditions in the Era of PCV13 Childhood and Adult Immunization
por: Pelton, Stephen I, et al.
Publicado: (2017)

1418. Pharmacokinetics (PK) and Toxicity of Intravenous Amikacin (AMK) Dosed Three Times a Week (TIW) for Treatment of Disseminated Mycobacterium abscessus Infection in Children
por: Tran, M Tuan, et al.
Publicado: (2018)

Impact of Prevnar vaccination on nasopharyngeal carriage of Streptococcus pneumoniae in healthy children in New Caledonia
por: Scotet, Julie, et al.
Publicado: (2011)

Clofazimine for Treatment of Mycobacterium abscessus Infections in Children
por: Adler-Shohet, Felice C, et al.
Publicado: (2017)

1432. Exploring Cell Wall Targets to Overcome Mycobacterium tuberculosis (Mtb): Ceftriaxone (CRO) Inhibits Ldt(Mt2), a Major Peptidoglycan (PG) Synthase
por: Nguyen, David C, et al.
Publicado: (2022)

1432. Touch-Free Automatic Alcohol-Based Hand Rub Dispensers in Healthcare Settings: A Simulation Study of Dispenser Energy Impact on Hand Hygiene Disruption
por: Chen, Nanshan, et al.
Publicado: (2023)

Poor Long-Term Efficacy of Prevnar-13 in Sickle Cell Disease Mice Is Associated with an Inability to Sustain Pneumococcal-Specific Antibody Titers
por: Szczepanek, Steven M., et al.
Publicado: (2016)

Booster immunization with a fractional dose of Prevnar 13 affects cell-mediated immune response but not humoral immunity in CD-1 mice
por: Catalioto, Rose-Marie, et al.
Publicado: (2021)

597 Increase in IPD incidence in Adults in 2013-2014 after 2 consecutive years of decline following introduction of 13-valent pneumococcal conjugate vaccine (PCV13)
por: Baxter, Roger, et al.
Publicado: (2014)

IpdE1-IpdE2 Is a Heterotetrameric Acyl Coenzyme A Dehydrogenase That Is Widely Distributed in Steroid-Degrading Bacteria
por: Gadbery, John E., et al.
Publicado: (2020)

Declines in invasive pneumococcal disease (IPD) during the COVID-19 pandemic in Los Angeles county
por: Van Groningen, Karinne M, et al.
Publicado: (2022)

176. Selected Impact of the 13-valent Pneumococcal Conjugate Vaccine (PCV13) on Invasive Pneumococcal Disease (IPD) at Eight Children’s Hospitals in the United States. 2014–2019
por: Kaplan, Sheldon L, et al.
Publicado: (2020)

IPD3 and IPD3L Function Redundantly in Rhizobial and Mycorrhizal Symbioses
por: Jin, Yue, et al.
Publicado: (2018)

PRIME-IPD SERIES Part 1. The PRIME-IPD tool promoted verification and standardization of study datasets retrieved for IPD meta-analysis
por: Dewidar, Omar, et al.
Publicado: (2021)

Increase of serotypes 15A and 23B in IPD in Germany in the PCV13 vaccination era
por: van der Linden, Mark, et al.
Publicado: (2015)

Decrease of invasive pneumococcal disease (IPD) in adults after introduction of pneumococcal 13-valent conjugate vaccine in Spain
por: Càmara, Jordi, et al.
Publicado: (2017)

911. Assessment of Representativeness of IPD Surveillance Conducted by the National Microbiology Laboratory of Canada
por: Nepal, Rajeev M, et al.
Publicado: (2020)

2401. Risk Factors for Antimicrobial Resistance in Invasive Pneumococcal disease (IPD) in Toronto, Canada, 2012–2017
por: Fear, Thomas, et al.
Publicado: (2018)

Total thyroidectomy as a method of choice in the treatment of Graves’ disease - analysis of 1432 patients
por: Bojic, Toplica, et al.
Publicado: (2015)

1888. A Nationwide Outbreak of Invasive Pneumococcal Disease (IPD) Caused by a Novel Streptococcus Pneumoniae Serotype 2 (SP2) Clone in the PCV13 Era, in Israel
por: Dagan, Ron, et al.
Publicado: (2019)

IPD—the Immuno Polymorphism Database
por: Robinson, James, et al.
Publicado: (2005)

IPD—the Immuno Polymorphism Database
por: Robinson, James, et al.
Publicado: (2010)

IPD—the Immuno Polymorphism Database
por: Robinson, James, et al.
Publicado: (2013)

IPD-IMGT/HLA Database
por: Robinson, James, et al.
Publicado: (2020)

The IPD-IMGT/HLA Database
por: Barker, Dominic J, et al.
Publicado: (2022)

Pediatric Invasive Pneumococcal Disease (IPD) in Yogyakarta, Indonesia: A Case Series
por: Arguni, Eggi, et al.
Publicado: (2022)

Neural Alterations in Interpersonal Distance (IPD) Cognition and Its Correlation with IPD Behavior: A Systematic Review
por: Huang, Xinxin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_60ebuvoeb8fam1ac4q2f8r68gj